Jena, Germany

Christine Skerka

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Csl Behring Gmbh. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Skerka. Retrieved from https://idiyas.com/inventor/christine-skerka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Skerka: Innovator in Chronic Nephropathies Treatment

Introduction

Christine Skerka is a notable inventor based in Jena, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of chronic nephropathies. Her innovative work has led to the development of a unique medicament that addresses various forms of this condition.

Latest Patents

Christine Skerka holds 1 patent for her invention titled "Factor H for the treatment of chronic nephropathies and production thereof." This invention pertains to the use of Factor H in manufacturing a medicament aimed at treating chronic nephropathies, both those not causally associated with proteinuria and those that are. Additionally, her patent includes large-scale purification methods for Factor H, showcasing her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Christine has worked with prominent organizations such as CSL Behring GmbH and Medizinische Hochschule Hannover. Her experience in these institutions has allowed her to refine her expertise and contribute to groundbreaking research in nephrology.

Collaborations

Christine has collaborated with esteemed colleagues, including Christoph Licht and Bernd Hoppe. These partnerships have further enriched her research and development efforts in the medical field.

Conclusion

Christine Skerka's innovative work in the treatment of chronic nephropathies exemplifies her dedication to improving patient outcomes through scientific advancements. Her contributions to medicine are invaluable and continue to inspire future research in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…